Table 2.
Study | HH Compliance/AHR Consumption | Active Rectal Screening (Targeted/Universal) | Additional Active Screening Strategies | Contact Isolation /Alert Code | Daily Chlorhexidine Baths | Cohorting Staff/patients | Closure/Stop Admissions | Environmental Disinfection | Environmental Cultures | Monitoring of Environmental Cleaning | Genotyping | Antimicrobial Stewardship/Monitoring of Antibiotic Consumption | Training /Education | Outcome |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Perez et al., 2020 [19] | ||||||||||||||
Cho et al., 2014 [26] | ||||||||||||||
Munoz-Price et al., 2014 [27] | ||||||||||||||
Valencia-Martìn et al., 2019 [28] | ||||||||||||||
Enfield et al., 2014 [29] | ||||||||||||||
Karampatakis et al., 2018 [30] | ||||||||||||||
Eckardt et al., 2022 [31] | ||||||||||||||
Chung et al., 2015 [32] | ||||||||||||||
Meschiari et al., 2020 [33] | ||||||||||||||
Zhao et al., 2019 [34] | ||||||||||||||
Ben-chetrit et al. [35] | ||||||||||||||
Metan et al., 2019 [36] | ||||||||||||||
All studies | ||||||||||||||
Legend: AHR, alcohol-based hand rubs; BA, before and after study; BHI, brain–heart infusion medium; CMA, centered moving average; CRAB, carbapenem-resistant Acinetobaster baumannii; CRAB_ID CRAB, incidence density; CS, cross-sectional study; DDD, defined daily doses; ERIC-PCR, Enterobacterial repetitive intergenic consensus; HH, hand hygiene; ICU, intensive care unit; NA, not available; PGFE, pulsed-field gel electrophoresis; BA, before and after analysis; WGS, whole-genome sequencing.